Avalyn Pharma Inc. Common Stock (AVLN) vs MannKind Corporation (MNKD)
A side-by-side comparison of Avalyn Pharma Inc. Common Stock and MannKind Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVLN
Avalyn Pharma Inc. Common Stock
$26.06HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
MNKD
MannKind Corporation
$3.82HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — AVLN vs MNKD
growth of $100 · dividends reinvested · last 1yAVLN -8.3% (-8.3%/yr)MNKD +36.9% (+36.9%/yr)MNKD compounded faster over this window
AVLN MNKD
AVLN vs MNKD: by the numbers
- •MNKD is the larger company ($1.22B vs $1.16B market cap).
- •Both run net losses; AVLN's is the smaller (0.00% vs -11.08% net margin).
Metrics side by side
Valuation
| Metric | AVLN | MNKD |
|---|---|---|
| P/S ratio | N/A | 3.10 |
| P/B ratio | 2.90 | N/A |
| EV / EBITDA | N/A | 52.46 |
Profitability
| Metric | AVLN | MNKD |
|---|---|---|
| Gross margin | 0.00% | 75.69% |
| Operating margin | 0.00% | 11.12% |
| Net margin | 0.00% | -11.08% |
| ROIC | -67.73% | 1.32% |
Growth (annualized)
| Metric | AVLN | MNKD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 39.51% |
| Total return CAGR (5Y) | N/A | -4.18% |
Go deeper
Dig into the metrics
Avalyn Pharma Inc. Common Stock ROEMannKind ROEAvalyn Pharma Inc. Common Stock operating marginMannKind operating marginAvalyn Pharma Inc. Common Stock revenue growthMannKind revenue growthAvalyn Pharma Inc. Common Stock free cash flowMannKind free cash flow
Avalyn Pharma Inc. Common Stock & MannKind appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.